Narayan S Hosmane
Overview
Explore the profile of Narayan S Hosmane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Coghi P, Ren Z, Hosmane N, Zhu Y
Med Res Rev
. 2024 Dec;
PMID: 39690514
Targeted charged alpha- and beta-particle therapies are currently being used in clinical radiation treatments as newly developed methods for either killing or controlling tumor cell growth. The alpha particles can...
2.
Zhang Y, Cai J, Hosmane N, Zhu Y
Eur J Med Chem
. 2024 Sep;
279:116841.
PMID: 39244862
Boron neutron capture therapy (BNCT) is a highly targeted, selective and effective technique to cure various types of cancers, with less harm to the healthy cells. In principle, BNCT treatment...
3.
Lesnikowski Z, Ekholm F, Hosmane N, Kellert M, Matsuura E, Nakamura H, et al.
Cells
. 2024 May;
13(10.
PMID: 38786022
Given the renewed interest in boron neutron capture therapy (BNCT) and the intensified search for improved boron carriers, as well as the difficulties of coherently comparing the carriers described so...
4.
Tang Z, Hou Y, Huang S, Hosmane N, Cui M, Li X, et al.
Acta Biomater
. 2024 Feb;
177:431-443.
PMID: 38307478
The noble metal NPs that are currently applied to photothermal therapy (PTT) have their photoexcitation location mainly in the NIR-I range, and the low tissue penetration limits their therapeutic effect....
5.
Zhang X, Lin Y, Hosmane N, Zhu Y
Med Rev (2021)
. 2024 Jan;
3(5):425-443.
PMID: 38283251
Boron neutron capture therapy (BNCT) is a potential radiation therapy modality for cancer, and tumor-targeted stable boron-10 (B) delivery agents are an important component of BNCT. Currently, two low-molecular-weight boron-containing...
6.
Coghi P, Li J, Hosmane N, Zhu Y
Med Res Rev
. 2023 Apr;
43(5):1809-1830.
PMID: 37102375
Boron neutron capture therapy (BNCT) is one of the most promising treatments among neutron capture therapies due to its long-term clinical application and unequivocally obtained success during clinical trials. Boron...
7.
Farheen J, Hosmane N, Zhao R, Zhao Q, Iqbal M, Kong X
Mater Today Bio
. 2022 Oct;
16:100450.
PMID: 36267139
Triple-negative breast cancer (TNBC) is the most violent class of tumor and accounts for 20-24% of total breast carcinoma, in which frequently rare mutation occurs in high frequency. The poor...
8.
Tabbakh F, Hosmane N, Tajudin S, Ghorashi A, Morshedian N
Sci Rep
. 2022 Oct;
12(1):17404.
PMID: 36258012
There are two major problems in proton therapy. (1) In comparison with the gamma-ray therapy, proton therapy has only ~ 10% greater biological effectiveness, and (2) the risk of the...
9.
Liu H, Zhou Z, Zhang Y, Chen N, Kang J, Liu G, et al.
Nanoscale Adv
. 2022 Sep;
1(5):1740-1745.
PMID: 36134240
In this work, modified biomass ash (MA), obtained through the hydrothermal treatment technique with biomass ash (BA) and alkaline phosphate as raw materials, was used as a useful soil amendment...
10.
Nandwana V, Nandwana N, Das Y, Saito M, Panda T, Das S, et al.
Molecules
. 2022 Jun;
27(11).
PMID: 35684340
Hundreds of billions of commensal microorganisms live in and on our bodies, most of which colonize the gut shortly after birth and stay there for the rest of our lives....